Literature DB >> 10794412

Crystal structure of adenosine kinase from Toxoplasma gondii at 1.8 A resolution.

W J Cook1, L J DeLucas, D Chattopadhyay.   

Abstract

Human infection with Toxoplasma gondii is an important cause of morbidity and mortality. Protozoan parasites such as T. gondii are incapable of de novo purine biosynthesis and must acquire purines from their host, so the purine salvage pathway offers a number of potential targets for antiparasitic chemotherapy. In T. gondii tachyzoites, adenosine is the predominantly salvaged purine nucleoside, and thus adenosine kinase is a key enzyme in the purine salvage pathway of this parasite. The structure of T. gondii adenosine kinase was solved using molecular replacement and refined by simulated annealing at 1.8 A resolution to an R-factor of 0.214. The overall structure and the active site geometry are similar to human adenosine kinase, although there are significant differences. The T. gondii adenosine kinase has several unique features compared to the human sequence, including a five-residue deletion in one of the four linking segments between the two domains, which is probably responsible for a major change in the orientation of the two domains with respect to each other. These structural differences suggest the possibility of developing specific inhibitors of the parasitic enzyme.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10794412      PMCID: PMC2144604          DOI: 10.1110/ps.9.4.704

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  33 in total

1.  Base pairing in DNA.

Authors:  J DONOHUE; K N TRUEBLOOD
Journal:  J Mol Biol       Date:  1960-12       Impact factor: 5.469

2.  Potent in vivo activity of arprinocid, a purine analogue, against murine toxoplasmosis.

Authors:  B J Luft
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

3.  Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii.

Authors:  M H Iltzsch; S S Uber; K O Tankersley; M H el Kouni
Journal:  Biochem Pharmacol       Date:  1995-05-17       Impact factor: 5.858

4.  Toxoplasma gondii: purine synthesis and salvage in mutant host cells and parasites.

Authors:  J D Schwartzman; E R Pfefferkorn
Journal:  Exp Parasitol       Date:  1982-02       Impact factor: 2.011

5.  Isolation and characterization of adenosine kinase from Leishmania donovani.

Authors:  A K Datta; D Bhaumik; R Chatterjee
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

6.  Cloning and expression of the adenosine kinase gene from rat and human tissues.

Authors:  T McNally; R J Helfrich; M Cowart; S A Dorwin; J L Meuth; K B Idler; K A Klute; R L Simmer; E A Kowaluk; D N Halbert
Journal:  Biochem Biophys Res Commun       Date:  1997-02-24       Impact factor: 3.575

7.  Structure of human adenosine kinase at 1.5 A resolution.

Authors:  I I Mathews; M D Erion; S E Ealick
Journal:  Biochemistry       Date:  1998-11-10       Impact factor: 3.162

8.  Kinetic studies of rat liver adenosine kinase. Explanation of exchange reaction between adenosine and AMP.

Authors:  M Mimouni; F Bontemps; G Van den Berghe
Journal:  J Biol Chem       Date:  1994-07-08       Impact factor: 5.157

9.  Intracranial infection in cardiac transplant recipients.

Authors:  R H Britt; D R Enzmann; J S Remington
Journal:  Ann Neurol       Date:  1981-02       Impact factor: 10.422

10.  Purification and properties of adenosine kinase from rat brain.

Authors:  Y Yamada; H Goto; N Ogasawara
Journal:  Biochim Biophys Acta       Date:  1980-12-04
View more
  8 in total

1.  Structures of adenosine kinase from Trypanosoma brucei brucei.

Authors:  Jennifer Timm; Dolores González-Pacanowska; Keith S Wilson
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2013-12-24       Impact factor: 1.056

Review 2.  Targeting purine and pyrimidine metabolism in human apicomplexan parasites.

Authors:  John E Hyde
Journal:  Curr Drug Targets       Date:  2007-01       Impact factor: 3.465

3.  Mutational analysis of the active-site residues crucial for catalytic activity of adenosine kinase from Leishmania donovani.

Authors:  Rupak Datta; Ishita Das; Banibrata Sen; Anutosh Chakraborty; Subrata Adak; Chhabinath Mandal; Alok K Datta
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

Review 4.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

5.  Adenosine kinase of Trypanosoma brucei and its role in susceptibility to adenosine antimetabolites.

Authors:  Alexandra Lüscher; Pinar Onal; Anne-Marie Schweingruber; Pascal Mäser
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

6.  Crystal structures of T. b. rhodesiense adenosine kinase complexed with inhibitor and activator: implications for catalysis and hyperactivation.

Authors:  Sabine Kuettel; Jason Greenwald; Dirk Kostrewa; Shaheen Ahmed; Leonardo Scapozza; Remo Perozzo
Journal:  PLoS Negl Trop Dis       Date:  2011-05-24

7.  Adenosine Kinase couples sensing of cellular potassium depletion to purine metabolism.

Authors:  Renata Rocha de Oliveira; Raphael Morales-Neto; Silvana Aparecida Rocco; Maurício Luis Sforça; Carla Cristina Polo; Celisa Caldana Costa Tonoli; Gustavo Fernando Mercaldi; Artur Torres Cordeiro; Mário Tyago Murakami; Kleber Gomes Franchini
Journal:  Sci Rep       Date:  2018-08-10       Impact factor: 4.379

Review 8.  Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases.

Authors:  An R Van Rompay; Magnus Johansson; Anna Karlsson
Journal:  Pharmacol Ther       Date:  2003-11       Impact factor: 12.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.